Add to calendar 09/16/2016 07:00 AM09/17/2016 08:00 PMASH Meeting on Hematologic MalignanciesHear the top experts in hematologic malignancies discuss the latest developments in clinical care and find answers to your most challenging patient care questions.Fairmont Chicago, Millennium Park, Chicago, ILMM/DD/YYYY129600
Get email updates Spread the word
Advance registration is open through August 22, 2016.Register now
Attend the 2016 ASH Meeting on Hematologic Malignancies to hear world-class experts in hematologic malignancies discuss the latest developments in clinical care, and learn how experts in the field treat their own patients based on the available data.
The majority of the program content will be structured as "How I Treat" sessions on core malignancies, including leukemia, lymphoma, myelodysplastic syndromes, myeloma, and myeloproliferative neoplasms. Each presentation will showcase the speaker's evidence-based treatment approaches, ranging from standard of care, specialized disease complications, and novel agent discussions. The meeting will also feature topic-based panel discussions which will allow participants to get answers to their most challenging patient care questions.
Kenneth C. Anderson, MD
Joseph M. Connors, MD
Vancouver Clinic, British Columbia Cancer Agency
Martin S. Tallman, MD
Memorial Sloan-Kettering Cancer Center
Program Planning Committee
- Kenneth C. Anderson, MD, Dana-Farber Cancer Institute
- Hetty Carraway, MD, Cleveland Clinic
- Joseph M. Connors, MD, British Columbia Cancer Agency
- Brad Kahl, MD, Washington University in St. Louis
- Ruben A. Mesa, MD, Mayo Clinic
- Wendy Stock, MD, University of Chicago
- Martin S. Tallman, MD, Memorial Sloan Kettering Cancer Center
- Celgene Corporation
- Incyte Corporation
- Pfizer, Inc.
- Seattle Genetics
- Takeda Oncology
- Teva Oncology
If your company is interested in sponsoring and/or exhibiting at this meeting, contact Thelma Barnett at email@example.com for more information.
back to top